Michael Deci is a Senior Scientist in Next Generation Biotherapeutics at Moderna since October 2020, focusing on antibody discovery, engineering, and development within various therapeutic areas, including immuno-oncology, autoimmunity, and infectious diseases. Prior to this role, Michael worked as a Scientist I in antibody discovery at Elevian, Inc. and conducted research as a Graduate Student Researcher at the University at Buffalo, where significant contributions included developing novel protein-based and nano-scale therapeutics for cancer treatment. Michael holds a PhD and a Master's degree in Pharmaceutical Sciences from the University at Buffalo and a Bachelor's degree in Chemistry from The College at Brockport, State University of New York.
This person is not in the org chart
This person is not in any teams
This person is not in any offices